Enveric Biosciences, Inc. (ENVB)
NASDAQ·Healthcare·Biotechnology
$5.32
+4.31%
Mkt Cap $1.18M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 27, 2026 | — | — | — | -$55.80 | $0.85 | +101.52% | — | — |
| Q4 2025 Nov 14, 2025 | — | — | — | -$63.00 | -$10.81 | +82.84% | — | — |
| Q3 2025 Aug 14, 2025 | — | — | — | -$63.00 | -$11.64 | +81.52% | — | — |
| Q2 2025 May 14, 2025 | — | — | — | -$6.00 | -$1.22 | +79.67% | — | — |
| Q1 2025 Mar 31, 2025 | — | $340.38K | — | -$3.45 | -$21.89 | -534.49% | — | — |
| Q4 2024 Nov 14, 2024 | — | — | — | -$7.80 | -$3.60 | +53.85% | — | — |
| Q3 2024 Aug 12, 2024 | — | — | — | -$8.25 | -$3.75 | +54.55% | — | — |
| Q2 2024 May 14, 2024 | — | — | — | -$9.15 | -$9.15 | +0.00% | — | — |
| Q1 2024 Mar 25, 2024 | — | $647.09K | — | -$23.24 | -$21.89 | +5.81% | — | — |
| Q4 2023 Nov 13, 2023 | — | — | — | -$28.94 | -$19.49 | +32.65% | — | — |
| Q3 2023 Aug 14, 2023 | — | — | — | -$0.65 | -$45.58 | -6912.31% | — | — |
| Q2 2023 Jun 8, 2023 | — | — | — | — | -$6.76 | — | — | — |
| Q2 2023 May 15, 2023 | — | — | — | -$33.45 | -$33.28 | +0.51% | — | — |
| Q4 2022 Nov 14, 2022 | — | — | — | -$4.00 | -$21.89 | -447.25% | — | — |
| Q3 2022 Aug 12, 2022 | — | — | — | -$3.83 | -$40.93 | -968.67% | — | — |
| Q2 2022 May 13, 2022 | — | — | — | -$6.00 | -$82.46 | -1274.33% | — | — |
| Q1 2022 Mar 31, 2022 | — | — | — | -$8.00 | -$104.95 | -1211.88% | — | — |
| Q4 2021 Nov 15, 2021 | — | — | — | -$8.00 | -$6.00 | +25.00% | — | — |
| Q3 2021 Aug 13, 2021 | — | — | — | -$8.75 | -$2.00 | +77.14% | — | — |
| Q2 2021 May 18, 2021 | — | — | — | — | -$149.93 | — | — | — |